Early Hydrogen–Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial
Lin Fa, Li Runting, Chen Yu, Yang Jun, Wang Ke, Jia Yitong, Han Heze, Hao Qiang, Shi Guangzhi, Wang Shuo, Zhao Yuanli, Chen Xiaolin · Trials · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

The publication “Early Hydrogen–Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial” is organized in H2HUBB under the research focus oxyhydrogen stroke and brain injury study 2024. The publication is cited as Lin Fa, Li Runting, Chen Yu, Yang Jun, Wang Ke, Jia Yitong, Han Heze, Hao Qiang, Shi Guangzhi, Wang Shuo, Zhao Yuanli, Chen Xiaolin, Trials, 2024. This study protocol examined Early Hydrogen–Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial. The abstract describes Planned or registered research population; hydrogen delivered as oxyhydrogen. The abstract reports: All results of the present study will be published in peer-reviewed journals and presented at relevant conferences. This is an automated editorial draft based on the abstract and requires source review before publication.
Oxyhydrogen stroke and brain injury study 2024 overview
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening neurosurgical emergency with a high mortality rate. Delayed cerebral ischemia (DCI) and cerebral vasospasm (CVS) are delayed… A protocol describes planned methods and does not provide completed outcome evidence.
Study design and hydrogen intervention
Publication type: Study protocol. Evidence type: Protocol or ongoing research. Research model or population: Planned or registered research population. Randomized: Yes. Blinding: Unknown. Control status: Unknown.
Delivery method: Oxyhydrogen. Hydrogen flow rate: 3 L/min. Dose or treatment amount: 3 L.
Reported findings and scientific interpretation
For this oxyhydrogen stroke and brain injury study 2024, the study record reports the following: The abstract reports: All results of the present study will be published in peer-reviewed journals and presented at relevant conferences.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA), a single-center, prospective, open-labeled, randomized controlled clinical trial, endeavors to evaluate the…
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.